Your browser doesn't support javascript.
loading
Experience and confidence in health technologies: evidence from malaria testing and treatment in Western Kenya.
Mangeni, Judith N; Abel, Lucy; Taylor, Steve M; Obala, Andrew; O'Meara, Wendy Prudhomme; Saran, Indrani.
Afiliação
  • Mangeni JN; School of Public Health, College of Health Sciences, Moi University, P.O BOX 512-30100, Eldoret, Kenya. nakholi2001@yahoo.com.
  • Abel L; Academic Model Providing Access to Healthcare, Moi Teaching and Referral Hospital, Eldoret, Kenya.
  • Taylor SM; Division of Infectious Diseases, School of Medicine, Duke University, Durham, NC, USA.
  • Obala A; School of Medicine, College of Health Sciences, Moi University, Eldoret, Kenya.
  • O'Meara WP; Duke Global Health Institute, Duke University, Durham, NC, USA.
  • Saran I; Boston College of Social Work, McGuinn Hall 305, Newton, MA, USA.
BMC Public Health ; 22(1): 1689, 2022 09 06.
Article em En | MEDLINE | ID: mdl-36068516
BACKGROUND: Low adoption of effective health technologies increases illness morbidity and mortality worldwide. In the case of malaria, effective tools such as malaria rapid diagnostic tests (RDTs) and artemisinin-combination therapies (ACTs) are both under-used and used inappropriately. Individuals' confidence in RDTs and ACTs likely affects the uptake of these tools. METHODS: In a cohort of 36 households (280 individuals) in Western Kenya observed for 30 months starting in June 2017, we examined if experience with RDTs and ACTs changes people's beliefs about these technologies and how those beliefs affect treatment behavior. Household members requested a free RDT from the study team any time they suspected a malaria illness, and positive RDT results were treated with a free ACT. We conducted annual, monthly, and sick visit surveys to elicit beliefs about the accuracy of malaria RDT results and the effectiveness of ACTs. Beliefs were elicited on a 5-point Likert scale from "very unlikely" to "very likely." RESULTS: Over the study period, the percentage of survey respondents that said a hypothetical negative RDT result was "very likely" to be correct increased from approximately 55% to 75%. Controlling for initial beliefs, people who had been tested at least once with an RDT in the past year had 3.6 times higher odds (95% CI [1 1.718 7.679], P = 0.001) of saying a negative RDT was "very likely" to be correct. Confidence in testing was associated with treatment behavior: those who believed a negative RDT was "very likely" to be correct had 1.78 times higher odds (95% CI [1.079 2.934], P = 0.024) of adhering to a negative RDT result (by not taking ACTs) than those who were less certain about the accuracy of negative RDTs. Adherence to a negative test also affected subsequent beliefs: controlling for prior beliefs, those who had adhered to their previous test result had approximately twice the odds (OR = 2.19, 95% CI [1.661 2.904], P < 0.001) of saying that a hypothetical negative RDT was "very likely" to be correct compared to those who had not adhered. CONCLUSIONS: Our results suggest that greater experience with RDTs can not only increase people's confidence in their accuracy but also improve adherence to the test result.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Malária Tipo de estudo: Diagnostic_studies Limite: Humans País/Região como assunto: Africa Idioma: En Revista: BMC Public Health Assunto da revista: SAUDE PUBLICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Quênia

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Malária Tipo de estudo: Diagnostic_studies Limite: Humans País/Região como assunto: Africa Idioma: En Revista: BMC Public Health Assunto da revista: SAUDE PUBLICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Quênia